Yahan Azithromycin ke baare mein ek complete aur detailed jawab hai Roman Urdu mein:
Azithromycin - Mukammal Jaankari
Drug Class (Dawai ki Kisam)
Azithromycin ek Macrolide Antibiotic hai. Yeh erythromycin se derive hoti hai - erythromycin ke lactone ring mein ek methylated nitrogen atom add karke banayi gayi hai, isliye isko 15-member lactone ring macrolide kaha jata hai (erythromycin 14-member hai).
Kaam Kaise Karta Hai? (Mechanism of Action)
- Bacterial ribosome ke 50S subunit se bind karta hai
- Protein synthesis band kar deta hai - translocation step ko rok kar
- Aam tor par bacteriostatic hai (bacteria ko marta nahi, rokta hai), lekin high doses par bactericidal bhi ho sakta hai
- Clindamycin aur chloramphenicol ka binding site bhi isi jagah ke qareeb hai
Kaunse Bacteria par Kaam Karta Hai? (Antibacterial Spectrum)
| Bacteria | Azithromycin ki Activity |
|---|
| Streptococcus pneumoniae | Active (resistance badh rahi hai) |
| Haemophilus influenzae | Erythromycin se zyada active |
| Moraxella catarrhalis | Zyada active |
| Chlamydia sp. | Bahut zyada (highly active) |
| Mycoplasma pneumoniae | Active |
| Legionella pneumophila | Active |
| Mycobacterium avium complex (MAC) | Active |
| Toxoplasma gondii | Active |
| Streptococci/Staphylococci | Erythromycin se thodi kum |
Pharmacokinetics (Dawai Jism Mein Kaise Behave Karti Hai)
1. Absorption:
- Stomach acid mein stable hai - achhi tarah absorb hoti hai
- Lekin khaana absorption mein delay kar sakta hai aur peak serum concentration kam kar deta hai
- IV formulation bhi available hai
2. Distribution - Azithromycin ki khaas baat:
- 500 mg dose ke baad serum concentration sirf ~0.4 mcg/mL hoti hai (yani blood mein kum)
- Lekin tissues aur phagocytic cells (neutrophils, macrophages, fibroblasts) mein serum se 10 se 100 guna zyada concentration hoti hai
- Sabse bada volume of distribution macrolides mein azithromycin ka hai
- CSF (cerebrospinal fluid) mein nahi pehunchi
3. Half-life - Azithromycin ki dusri khaas baat:
- Tissue half-life: 2-4 din
- Elimination half-life: ~3 din (68 ghante)
- Isi wajah se once-daily dosing aur short courses mumkin hain
4. Excretion:
- Mainly bile ke zariye active drug ke roop mein nikalta hai
- Urine mein sirf <10% nikalta hai
- Hepatic dysfunction mein dawai jama ho sakti hai - savdhaani zaruri
Clinical Uses (Istimaal)
| Bimari | Dose |
|---|
| Community-Acquired Pneumonia (CAP) | 500 mg loading dose, phir 250 mg/day x 4 din |
| Chlamydial cervicitis/urethritis | Single 1g dose (ek hi baar mein) |
| Atypical pneumonia (Mycoplasma, Legionella) | Preferred option |
| MAC prophylaxis (AIDS patients mein) | Once weekly azithromycin |
| COPD/Cystic Fibrosis mein anti-inflammatory | Long-term low dose |
Drug Interactions - IMPORTANT ADVANTAGE
Azithromycin cytochrome P450 enzymes ko inhibit NAHI karta (kyunki iska 15-member ring hai, 14-member nahi). Isliye erythromycin aur clarithromycin ki tarah drug interactions nahi hoti.
- Erythromycin aur clarithromycin - CYP3A4 inhibitor hain, bahut drug interactions
- Azithromycin - CYP3A4 safe hai
Aluminum/Magnesium antacids - bioavailability nahi badlaate lekin absorption thoda delay kar dete hain.
Resistance
Bacteria azithromycin ke against resistance kaise develop karta hai:
- Drug ka uptake band kar deta hai
- Efflux pumps use karke drug bahar nikal deta hai
- 23S rRNA mein adenine ka methylation - 50S subunit ki drug se affinity kam hoti hai
- Gram-negative organisms mein plasmid-associated esterases
Erythromycin-resistant streptococci aur staphylococci azithromycin ke against bhi resistant hote hain (cross-resistance).
Side Effects (Nuqsanaat)
| Side Effect | Detail |
|---|
| GI upset | Erythromycin se kum, lekin ho sakta hai |
| QT prolongation | Cardiac arrhythmia ka risk - proarrhythmic conditions mein saavdhaani |
| Cardiac death | Research mein small increased risk mili hai |
| Ototoxicity | Azithromycin ke sath irreversible sensorineural hearing loss report hua hai |
| Hepatic accumulation | Liver disease mein savdhaani |
Immunomodulatory Property - Extra Feature
Azithromycin sirf antibiotic hi nahi - iska anti-inflammatory effect bhi hai:
- Pro-inflammatory cytokines ka release kam karta hai
- Lungs ki epithelial cells mein chronic inflammation reduce karta hai
- Isliye COPD, cystic fibrosis, CAP mein extra faida deta hai
Macrolides Ka Comparison (Summary Table)
| Property | Erythromycin | Clarithromycin | Azithromycin |
|---|
| Oral absorption | Acid se kharab hoti | Stable | Stable |
| Half-life | 2 ghante | 3.5 ghante | 68 ghante |
| CYP3A4 inhibition | Haan | Haan | Nahi |
| Urine excretion | <15% | 30-50% | <10% |
| Active metabolite | Nahi | Haan | Nahi |
| Dosing | 3-4 baar/din | 2 baar/din | 1 baar/din |
Sources: Katzung's Basic and Clinical Pharmacology 16th Ed., p. 1273-1274 | Lippincott Illustrated Reviews Pharmacology, p. 998-1005